Anecdotal pricing and stale invoices don’t survive cross-examination. Cannabis Benchmarks® and Hemp Benchmarks® — IOSCO-aligned, cited by the WSJ, listed on Nasdaq, built on the same methodology as S&P Global Platts — give your argument a foundation no opposing expert can dislodge.
In every cannabis and hemp dispute — crop loss, royalty, receivership, or tax — the opposing expert commonly introduces blended averages, stale invoices, and unsourced trade estimates. Without a defensible market anchor, even a well-constructed damages argument is exposed.
Cannabis Benchmarks® and Hemp Benchmarks® are built on the same methodology as S&P Global Platts — operated by the same people. IOSCO-aligned. Listed on Nasdaq. Cited by the Wall Street Journal. Referenced by CME. 27+ U.S. state markets covered.
Tier 1 — Case Strategy Kit (scoping)
Tier 2 — Certified Historical Database
Tier 3 — Expert Witness Defense Pack
Tier 4 — Receivership Mark-to-Market Feed
Now includes 280E corrective reports and post-Schedule III asset valuation overlays.
Every item on the left is a liability in deposition. Every item on the right is a defensible position backed by a documented, independently verifiable methodology.
Status as a third-party Price Reporting Agency — neither buyer nor seller — insulates expert testimony from “self-serving data” challenges during cross-examination. NLDS takes no position in the cannabis and hemp markets. The data reflects what the market does, not what any participant wants it to say.
Litigation frequently concerns events two, three, or five years prior. Weekly wholesale price history dating to April 2015 enables credible “but-for” analysis and trend normalization across the full damages window. No competitor can backfill this dataset retroactively — it took eleven years to build.
Distinct volume-weighted assessments for indoor, greenhouse, and outdoor cultivation — plus Trim, Fresh Frozen, Biomass, and Distillate. Indoor cannabis flower prices run 100–250% above outdoor. Packaged units carry a 115% premium over bulk. Experts who testify to a blended number aren’t simplifying — they’re misrepresenting.
IOSCO-aligned methodology narratives, peer recognition from Nasdaq, CME, and WSJ, and in-field price reporter validation produce the “replicability and peer recognition” courts require under Daubert. Every data export can be accompanied by a signed methodology declaration. The full assessment methodology is publicly documented at cannabisbenchmarks.com/methodology.
Four tiers structured to match where you are in the litigation lifecycle — from pre-case scoping through trial testimony and receivership.
The entry point before committing to full expert work. Delivers a snapshot of pricing and market conditions to validate the damages opportunity and quantify the litigation ROI — so counsel can assess exposure before engaging a full expert team.
Delivered within 3–5 business days of engagement execution.
Counsel assessing damages exposure before committing to expert retention.
The complete state-level, grow-type-specific price export with a Certificate of Authenticity, methodology statement ready for opposing counsel disclosure, and a preliminary damages assessment situating the benchmark data within the context of the specific claim. Also the foundation for 280E corrective reports — see § 5.0.
Delivered within 5–7 business days. Rush available at 50% surcharge.
The 280E corrective report is a certified export, scoped for Overhead Expenses verification and amended return support.
Full-service expert engagement from discovery through trial. NLDS principals deliver affirmative or rebuttal expert reports, live deposition and testimony support, and systematic dismantling of opposing pricing theories.
CFO-level financial modeling + GC-level methodology defensibility. Most providers offer one. This desk offers both.
Zero successful Daubert challenges across all Tier 3 engagements to date.
Receivers and trustees owe a fiduciary duty requiring defensible asset valuation. Independent benchmark pricing provides the “Shield of Reasonableness” that protects against undervaluation claims from creditors. Now includes a post-Schedule III appraisal overlay for proceedings where assets were valued under pre-rescheduling assumptions.
Protects receivers from undervaluation claims. Prevents fire-sale outcomes from being imposed on creditors.
Relevant to Cannabist Co. (Case 26-10426) and similar proceedings where pre-rescheduling valuations are now challengeable.
The Litigation Support Desk is no longer just about defensible damages — it is now the primary tool for capital recovery in the post-Schedule III environment.
Supporting amended cannabis tax returns for tax years 2023–2025. The April 22, 2026 DOJ Final Order placing state-licensed medical cannabis in Schedule III opens a window for retroactive Overhead Expenses deduction claims previously barred under IRC § 280E. Protective claims for 2023–2025 are actively being filed. A state-level historical price export with Certificate of Authenticity, scoped for Overhead Expenses and inventory price verification.
Built For: Cannabis tax attorneys, CPAs, MSO CFOs and Tax Directors.
Protective claim window is open now. The June 29, 2026 hearing on bifurcation may narrow scope. Act before that date.
DOJ Final Order — April 22, 2026. Immediate effect for state-licensed medical operators.
Defending IRS expense allocation challenges for operators with co-located medical and adult-use facilities. This engagement begins as a Tier 2 certified data export and escalates to a Tier 3 expert engagement if challenged in Tax Court. Time-bounded: the legal framework may shift materially following the June 29, 2026 hearing resolving the Schedule I/III bifurcation question.
Built For: Cannabis tax attorneys, operations counsel, MSO finance teams.
June 29, 2026 hearing determines bifurcation framework. This engagement collapses or expands depending on that ruling.
Tier 2 for IRS response. Tier 3 if Tax Court challenge requires expert report or testimony.
Pre- vs. post-rescheduling valuation lift quantification for receivers, monitors, and trustees in active proceedings. Specifically relevant where cannabis assets were sold or valued under “distress” assumptions calculated under Schedule I — before the April 22, 2026 reclassification materially changed the regulatory and tax environment. Relevant to Cannabist Co. (Case 26-10426) and similar active matters.
Built For: Receivers, bankruptcy monitors, creditor counsel, secured lenders.
Cannabist Co. Case 26-10426 and similar proceedings where pre-rescheduling valuations may be challengeable.
Layered onto existing Tier 4 feed. Requires no new data subscription — same contributor network, new appraisal scope.
Below is a sample of litigation engagements NLDS has supported across six different case types — plaintiff, defense, and creditor. Click any row to expand the case record.
| Docket Ref. | Case Type | Side | Jurisdiction | Detail |
|---|---|---|---|---|
| LSD-001 | Fire / Crop Loss | Plaintiff | Federal | |
|
Matter
PG&E Fire Victim Trust — Cannabis Crop Damages. Counsel retained NLDS to license Cannabis Benchmarks price data, prepare market-based damages visuals, and support a claimant-side declaration and testimony through multiple appeal hearing stages. Work Performed
Licensed Cannabis Benchmarks® historical data. Prepared state-specific damages visuals. Supported declaration and expert testimony. Rebuttal report delivered post-hearing. Outcome
Rebuttal to opposing pricing assumptions sustained through appeal. Revised expert opinion delivered post-hearing. Daubert challenge: none. |
||||
| LSD-002 | Royalty Dispute | Defense | State | |
|
Matter
Royalty Damages Rebuttal. Defense counsel sought to refute and narrow claimant’s royalty valuation. NLDS refocused the royalty theory from finished-product revenue to only the value of extracted crude oil. NLDS built the damages model, filed the rebuttal report, and supported deposition defense. Work Performed
Royalty theory narrowing from finished product to crude oil value. Rebuttal report filed. Deposition support through close. Outcome
Material flaws in plaintiff’s damages analysis identified and documented. Supplemental report issued post-deposition. Daubert challenge: none. |
||||
| LSD-003 | Hemp Arbitration | Defense | Arbitration | |
|
Matter
Hemp Biomass Damages — Arbitration Rebuttal. The case arose out of a failed start up joint venture that was to construct a facility for the processing of hemp biomass into CBD distillate and isolate. Work Performed
NLDS prepared a rebuttal report challenging drying capacity and CBD compliance assumptions, reducing damage claim by multiple orders of magnitude. Hemp Benchmarks® pricing data and awareness of contemporaneous market dynamics applied throughout. Outcome
Unrealistic operational hypotheticals challenged on drying capacity and CBD compliance grounds during live testimony. Daubert challenge: none. |
||||
| LSD-004 | Lost Profits & Business Value | Plaintiff | Missouri | |
|
Matter
Missouri Cultivator — Lost Profits & Enterprise Value. Retained by counsel to quantify lost profits and lost business value for a cultivator whose Missouri license application was disrupted. Analysis included EBITDA modeling, terminal value, and Missouri-specific legal standards alignment. Work Performed
Expert report with full damages model. Comparable-company benchmarks. EBITDA and terminal value modeling. State-specific legal standards review. Scenario refinement for settlement. Outcome
Expert report delivered with full damages model, comparable-company benchmarks, and scenario refinement for settlement discussions. Daubert challenge: none. |
||||
| LSD-005 | Wrongful Eradication | Plaintiff | California | |
|
Matter
Hemp Eradication — Retained to quantify damages from the alleged wrongful eradication of hemp. Work spanned affirmative report, rebuttal, and deposition support — matching APN records, THC test results, and plant-destruction records to Hemp Benchmarks® pricing. Work Performed
Affirmative and rebuttal reports delivered. APN record, THC test, and destruction record matching. Deposition support and live testimony prep completed through March 2026. Outcome
Affirmative and rebuttal reports delivered. Deposition and live testimony support completed. Matter continues. Daubert challenge: none. |
||||
| LSD-006 | Insolvency / Secured Lender | Creditor | Multi-State | |
|
Matter
Operator Insolvency — Retained by the ABC Trustee as the exclusive financial advisor to perform a corporate valuation of this publicly traded company with a sell-side mandate. Work Performed
Fair Market Value of individual business units of this vertically integrated operation were determined using the financial performance and earning capacity of each unit, along with an analysis of comparable Enterprise Value metrics. Led outreach to more than 95 vetted potential strategic and financial acquirers. Outcome
Court-approved valuation adjusted significantly upward. Valuation gap closed. NLDS methodology recognized as industry standard during proceedings. Daubert challenge: none. |
||||
A 280E corrective report is a certified historical wholesale price export — scoped for Overhead Expenses and inventory price verification — used to support amended cannabis tax returns. Following the April 22, 2026 DOJ Final Order placing state-licensed medical cannabis in Schedule III, operators may be entitled to retroactive Overhead Expenses deductions previously disallowed under IRC § 280E. Protective claims for cannabis Overhead Expenses verification and amended tax returns for tax years 2023–2025 are actively being filed. This is a Tier 2 SKU from the NLDS Litigation Support Desk.
Attorneys, forensic accountants, insurance adjusters, receivers, and trustees working on cannabis & hemp disputes require cannabis wholesale price data that survives cross-examination. IOSCO-aligned methodology — the same standard used by S&P Global Platts and Argus Media — provides the peer-reviewed, documented, replicable framework courts require under Daubert. Self-reported prices, broker quotes, and blended invoice averages do not meet this standard and are routinely challenged on cross.
The April 22, 2026 DOJ Final Order reclassifying state-licensed medical cannabis as Schedule III has material implications for active proceedings: asset valuations calculated under Schedule I assumptions may now be challengeable; tax claims previously barred by IRC § 280E may become viable for retroactive recovery; and receivership proceedings may need updated mark-to-market appraisals. The June 29, 2026 hearing will resolve the medical/adult-use bifurcation question. Counsel should act before that hearing closes the window on bifurcation apportionment strategies.
Tier 1 (Case Strategy Kit) delivers a snapshot of pricing and market conditions to validate damages opportunity for pre-case ROI scoping — typically within 3–5 business days. Tier 2 (Certified Historical Database) provides a full state-level, grow-type-specific export with Certificate of Authenticity, used for discovery, damages modeling, and 280E corrective reports. Tier 3 (Expert Witness Defense Pack) covers methodology documentation, Daubert-ready affidavit, expert reports, and live testimony for active litigation. Tier 4 (Receivership Mark-to-Market Feed) provides dedicated inventory valuation for fiduciaries and court reporting support, including post-Schedule III valuation overlays.
NLDS Cannabis Benchmarks® and Hemp Benchmarks® data has been submitted as certified wholesale price evidence in litigation engagements across multiple case types with zero successful Daubert challenges to date. The methodology is publicly documented at cannabisbenchmarks.com/methodology, peer-recognized by Nasdaq and CME, and cited by the Wall Street Journal. The data collection, validation, outlier-elimination, and volume-weighting protocols satisfy the testability and peer-review prongs courts apply under Daubert v. Merrell Dow Pharmaceuticals.
Tier 1 Case Strategy Kits are typically delivered within 3–5 business days. Tier 2 Certified Historical Database exports can be delivered within 5–7 business days. Tier 3 Expert Witness Defense Pack engagements are scoped to the litigation timeline. Rush turnarounds (48–72 hours) are available at a 50% surcharge.
The Litigation Support Desk operates on the timeline of litigation — not a subscription service. The 280E window closes with the June 29 hearing. Reach out before your disclosure window does.